Resultats a la cerca d'autor

1

Carregant...

Editorial: Advances in The Therapy of Atrial Fibrillation: Incrementally Progressive But Not Without Missteps

per Reiffel, James A
Publicat 2014

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

2

Carregant...

Are we at the Goal Line with the Novel Oral Anticoagulants and Have We Reached the End of the Line for Dronedarone and Vernakalant – or is There More to Come?

per Reiffel, James A
Publicat 2014

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

3

Carregant...

Does the FDA Owe Us an Explanation?

per Reiffel, James A
Publicat a J Atr Fibrillation (2015)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

4

Carregant...

The Power of One: a Highly Detailed, Log-Based, Case Example that Clearly Demonstrates the Effective Use of Ranolazine for the Control of Progressive Atrial Fibrillationn

per Reiffel, James A
Publicat a J Atr Fibrillation (2010)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

5

Carregant...

The New Novel Oral Anticoagulants (NOACs) In Patients With Atrial Fibrillation: Dogma, Dilemmas, And Decisions On Dosing

per Reiffel, James A
Publicat a J Atr Fibrillation (2014)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

6

Carregant...

GIANT Flutter Waves in ECG Lead V1: a Marker of Pulmonary Hypertension

per Reiffel, James A
Publicat a J Atr Fibrillation (2008)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

7

Carregant...

Dronedarone: Where Does it Fit in the AF Therapeutic Armamentarium?

per Reiffel, James A
Publicat a J Atr Fibrillation (2013)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

8

Carregant...

Dronedarone For Atrial Fibrillation: Unbridled Enthusiasm Or Just Another Small Step Forward?

per Reiffel, James A
Publicat a J Atr Fibrillation (2009)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

9

Carregant...

Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?

per Reiffel, James A
Publicat a J Atr Fibrillation (2008)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

10

Carregant...

The Anticoagulated Atrial Fibrillation Patient Who Requires “Curative” Therapy for Prostate Carcinoma: a Bleeding Conundrum

per Reiffel, James A
Publicat a J Atr Fibrillation (2008)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

11

Carregant...

Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?

per Reiffel, James A
Publicat a Arrhythm Electrophysiol Rev (2017)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

12

Carregant...

Complexities in the Atrial Fibrillation-Stroke Relationship: Improving Comprehension of Temporal Discordance, Magnitude Synergism, and Subclinical Atrial Fibrillation -- Three Sour...

per Reiffel, James A.
Publicat a J Atr Fibrillation (2018)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

13

Carregant...

Propensity-Score Matching: Optimal, Adequate, or Incomplete?

per Reiffel, James A.
Publicat a J Atr Fibrillation (2018)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

14

Carregant...

Practical algorithms for pharmacologic management of the post myocardial infarction patient

per Reiffel, James A.
Publicat a Clin Cardiol (2009)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

15

Carregant...

Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?

per Reiffel, James A.
Publicat a J Innov Card Rhythm Manag (2020)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

16

Carregant...

TTR: Time in Therapeutic Range or “The Troublesome Report”?

per Reiffel, James A.
Publicat a J Innov Card Rhythm Manag (2019)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

17

Carregant...

When Silence Isn’t Golden: The Case of “Silent” Atrial Fibrillation

per Reiffel, James A.
Publicat a J Innov Card Rhythm Manag (2017)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

18

Carregant...

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation

per Reiffel, James A.
Publicat a J Innov Card Rhythm Manag (2018)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

19

Carregant...

Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation

per Reiffel, James A.
Publicat a J Innov Card Rhythm Manag (2018)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

20

Carregant...

Oral Anticoagulant Therapy: When What Should Not Be Is and What Should Be Is Not

per Reiffel, James A.
Publicat a J Innov Card Rhythm Manag (2019)

Obtenir text complet
Obtenir text complet
Obtenir text complet

Artigo

Afineu la vostra cerca